Download | < Back |
25 Jan 2024 | |
Jiangsu Alphamab Biopharmaceuticals, 3D Medicines (Beijing) and Glenmark announce the signing of a License Agreement for KN035 (Envafolimab) for Multiple Geographies around the World | |
View all announcements for GLENMARK PHARMACEUTICALS LTD. | Source: BSE India |